330 related articles for article (PubMed ID: 17641038)
21. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12.
Zou W; Borvak J; Marches F; Wei S; Galanaud P; Emilie D; Curiel TJ
J Immunol; 2000 Oct; 165(8):4388-96. PubMed ID: 11035076
[TBL] [Abstract][Full Text] [Related]
22. Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells.
Loré K; Smed-Sörensen A; Vasudevan J; Mascola JR; Koup RA
J Exp Med; 2005 Jun; 201(12):2023-33. PubMed ID: 15967828
[TBL] [Abstract][Full Text] [Related]
23. CD34-derived dendritic cells transfected ex vivo with HIV-Gag mRNA induce polyfunctional T-cell responses in nonhuman primates.
Romain G; van Gulck E; Epaulard O; Oh S; Li D; Zurawski G; Zurawski S; Cosma A; Adam L; Chapon C; Todorova B; Banchereau J; Dereuddre-Bosquet N; Vanham G; Le Grand R; Martinon F
Eur J Immunol; 2012 Aug; 42(8):2019-30. PubMed ID: 22585548
[TBL] [Abstract][Full Text] [Related]
24. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
Barouch DH; Pau MG; Custers JH; Koudstaal W; Kostense S; Havenga MJ; Truitt DM; Sumida SM; Kishko MG; Arthur JC; Korioth-Schmitz B; Newberg MH; Gorgone DA; Lifton MA; Panicali DL; Nabel GJ; Letvin NL; Goudsmit J
J Immunol; 2004 May; 172(10):6290-7. PubMed ID: 15128818
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.
Quinn KM; Da Costa A; Yamamoto A; Berry D; Lindsay RW; Darrah PA; Wang L; Cheng C; Kong WP; Gall JG; Nicosia A; Folgori A; Colloca S; Cortese R; Gostick E; Price DA; Gomez CE; Esteban M; Wyatt LS; Moss B; Morgan C; Roederer M; Bailer RT; Nabel GJ; Koup RA; Seder RA
J Immunol; 2013 Mar; 190(6):2720-35. PubMed ID: 23390298
[TBL] [Abstract][Full Text] [Related]
28. Langerhans cells are more efficiently transduced than dermal dendritic cells by adenovirus vectors expressing either group C or group B fibre protein: implications for mucosal vaccines.
Rozis G; de Silva S; Benlahrech A; Papagatsias T; Harris J; Gotch F; Dickson G; Patterson S
Eur J Immunol; 2005 Sep; 35(9):2617-26. PubMed ID: 16114109
[TBL] [Abstract][Full Text] [Related]
29. Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.
Havenga M; Vogels R; Zuijdgeest D; Radosevic K; Mueller S; Sieuwerts M; Weichold F; Damen I; Kaspers J; Lemckert A; van Meerendonk M; van der Vlugt R; Holterman L; Hone D; Skeiky Y; Mintardjo R; Gillissen G; Barouch D; Sadoff J; Goudsmit J
J Gen Virol; 2006 Aug; 87(Pt 8):2135-2143. PubMed ID: 16847108
[TBL] [Abstract][Full Text] [Related]
30. Early adenoviral gene expression mediates immunosuppression by transduced dendritic cell (DC): implications for immunotherapy using genetically modified DC.
Tuettenberg A; Jonuleit H; Tüting T; Brück J; Biermann V; Kochanek S; Knop J; Enk AH
J Immunol; 2004 Feb; 172(3):1524-30. PubMed ID: 14734730
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk between human DC subsets promotes antibacterial activity and CD8+ T-cell stimulation in response to bacille Calmette-Guérin.
Lozza L; Farinacci M; Faé K; Bechtle M; Stäber M; Dorhoi A; Bauer M; Ganoza C; Weber S; Kaufmann SH
Eur J Immunol; 2014 Jan; 44(1):80-92. PubMed ID: 24114554
[TBL] [Abstract][Full Text] [Related]
32. Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals.
Fuchs JD; Bart PA; Frahm N; Morgan C; Gilbert PB; Kochar N; DeRosa SC; Tomaras GD; Wagner TM; Baden LR; Koblin BA; Rouphael NG; Kalams SA; Keefer MC; Goepfert PA; Sobieszczyk ME; Mayer KH; Swann E; Liao HX; Haynes BF; Graham BS; McElrath MJ;
J AIDS Clin Res; 2015 May; 6(5):. PubMed ID: 26587311
[TBL] [Abstract][Full Text] [Related]
33. Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells.
Smed-Sörensen A; Loré K; Vasudevan J; Louder MK; Andersson J; Mascola JR; Spetz AL; Koup RA
J Virol; 2005 Jul; 79(14):8861-9. PubMed ID: 15994779
[TBL] [Abstract][Full Text] [Related]
34. Vaccines expressing the innate immune modulator EAT-2 elicit potent effector memory T lymphocyte responses despite pre-existing vaccine immunity.
Aldhamen YA; Seregin SS; Schuldt NJ; Rastall DP; Liu CJ; Godbehere S; Amalfitano A
J Immunol; 2012 Aug; 189(3):1349-59. PubMed ID: 22745373
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.
Ranieri E; Herr W; Gambotto A; Olson W; Rowe D; Robbins PD; Kierstead LS; Watkins SC; Gesualdo L; Storkus WJ
J Virol; 1999 Dec; 73(12):10416-25. PubMed ID: 10559360
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells.
Cheng C; Gall JG; Kong WP; Sheets RL; Gomez PL; King CR; Nabel GJ
PLoS Pathog; 2007 Feb; 3(2):e25. PubMed ID: 17319743
[TBL] [Abstract][Full Text] [Related]
37. Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells.
Douagi I; Gujer C; Sundling C; Adams WC; Smed-Sörensen A; Seder RA; Karlsson Hedestam GB; Loré K
J Immunol; 2009 Feb; 182(4):1991-2001. PubMed ID: 19201852
[TBL] [Abstract][Full Text] [Related]
38. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus.
Domingues R; de Carvalho GC; Aoki V; da Silva Duarte AJ; Sato MN
J Transl Med; 2016 Jun; 14(1):171. PubMed ID: 27286889
[TBL] [Abstract][Full Text] [Related]
39. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
[TBL] [Abstract][Full Text] [Related]
40. Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotype.
Tong O; Duette G; O'Neil TR; Royle CM; Rana H; Johnson B; Popovic N; Dervish S; Brouwer MAE; Baharlou H; Patrick E; Ctercteko G; Palmer S; Lee E; Hunter E; Harman AN; Cunningham AL; Nasr N
PLoS Pathog; 2021 Apr; 17(4):e1009522. PubMed ID: 33872331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
